Thu, Mar 5, 2015, 2:06 PM EST - U.S. Markets close in 1 hr 54 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • alexp1112 alexp1112 Mar 1, 2012 11:26 AM Flag

    Buy or watch?

    I owned shares in IMUC about a year ago but sold. Good company with lots of potential. Their product is also targeting the pt population that I work with.

    At this point, do you believe it worth buying based on anticipated AMEX listing or buy at another time before data is due out for phase 2?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thank you. I agree with your assessment and independently came to the same conclusions. I think my holdup is a bit mental. The last time I bought...there was hype about AMEX listing and then the pps fell off. I lost a bit of money. This time around feels similar but the big difference is obviously that they are more advanced in clinical trials. And good results are anticipated. I will probably try to wait and buy around 2.2 and if it falls below 2, have enough flexibility to average down. GL

    • Good question. I think with an obviously pending AMEX listing and high expectations for solid P2 results it will go higher until results come out. My guess would be a $200 million market cap by the time the results are released. JMHO. The closer you purchase shares near 2 the better but it may or may not get back to that level.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.